🇺🇸 FDA
Patent

US 10894966

Virus-based expression vectors and uses thereof

granted A61KA61K2039/5256A61K35/76

Quick answer

US patent 10894966 (Virus-based expression vectors and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K2039/5256, A61K35/76, A61K39/145, A61K48/0066